Skip to main content
PMC home page
Journal of Clinical Pathology. Supplement (Association of Clinical Pathologists) logoLink to Journal of Clinical Pathology. Supplement (Association of Clinical Pathologists)
. 1970;4:60–70. doi: 10.1136/jcp.s1-4.1.60

Enzyme assays in diseases of the heart and skeletal muscle.

S B Rosalki
PMCID: PMC1176286  PMID: 4949709

Full text

PDF
60

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AEBI U., RICHTERICH R., STILLHART H., COLOMBO J. P., ROSSI E. [Progressive muscular dystrophy. III. Serum enzymes in muscular dystrophy in childhood]. Helv Paediatr Acta. 1961 Dec;16:543–564. [PubMed] [Google Scholar]
  2. AGRESS C. M. Evaluation of the transaminase test. Am J Cardiol. 1959 Jan;3(1):74–93. doi: 10.1016/0002-9149(59)90398-4. [DOI] [PubMed] [Google Scholar]
  3. Agostoni A., Ideo G., Stabilini R. Serum gamma-glutamyl transpeptidase activity in myocardial infarction. Br Heart J. 1965 Sep;27(5):688–690. doi: 10.1136/hrt.27.5.688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. BAUMANN P., ESCHER J., RICHTERICH R. [The behavior of serum enzymes in muscular work]. Schweiz Z Sportmed. 1962;10:33–51. [PubMed] [Google Scholar]
  5. BEARN A. G., VESELL E. S. Localization of lactic acid dehydrogenase activity in serum fractions. Proc Soc Exp Biol Med. 1957 Jan;94(1):96–99. doi: 10.3181/00379727-94-22866. [DOI] [PubMed] [Google Scholar]
  6. Brody I. A., Hatcher M. A. Origin of increased serum creatine phosphokinase in tetanus. An isoenzyme analysis. Arch Neurol. 1967 Jan;16(1):89–93. doi: 10.1001/archneur.1967.00470190093011. [DOI] [PubMed] [Google Scholar]
  7. CHESLER E. Serum glutamic oxalacetic transaminase levels in diphtheritic myocarditis. Br Heart J. 1958 Apr;20(2):244–248. doi: 10.1136/hrt.20.2.244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. CHINSKY M., SHERRY S. Serum transaminase as a diagnostic aid. AMA Arch Intern Med. 1957 Apr;99(4):556–568. doi: 10.1001/archinte.1957.00260040056006. [DOI] [PubMed] [Google Scholar]
  9. COHEN L., DJORDJEVICH J., ORMISTE V. SERUM LACTIC DEHYDROGENASE ISOZYME PATTERNS IN CARDIOVASCULAR AND OTHER DISEASES, WITH PARTICULAR REFERENCE TO ACUTE MYOCARDIAL INFARCTION. J Lab Clin Med. 1964 Sep;64:355–374. [PubMed] [Google Scholar]
  10. DACK S. POSTOPERATIVE MYOCARDIAL INFARCTION. Am J Cardiol. 1963 Oct;12:423–430. doi: 10.1016/0002-9149(63)90171-1. [DOI] [PubMed] [Google Scholar]
  11. DREYFUS J. C., SCHAPIRA G. L'activité transaminasique du sérum au cours des myopathies. C R Seances Soc Biol Fil. 1955 Nov;149(21-22):1934–1935. [PubMed] [Google Scholar]
  12. DREYFUS J. C., SCHAPIRA G., RESNAIS J., SCEBAT L. [Serum creatine kinase in the diagnosis of myocardial infarct]. Rev Fr Etud Clin Biol. 1960 Apr;5:386–387. [PubMed] [Google Scholar]
  13. DREYFUS J. C., SCHAPIRA G., SCHAPIRA F. Serum enzymes in the physiopathology of muscle. Ann N Y Acad Sci. 1958 Oct 13;75(1):235–249. doi: 10.1111/j.1749-6632.1958.tb36870.x. [DOI] [PubMed] [Google Scholar]
  14. Dempsey J. J., Salem H. H. An enzymatic electrocardiographic study on toxicity of dehydroemetine. Br Heart J. 1966 Jul;28(4):505–511. doi: 10.1136/hrt.28.4.505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Denborough M. A., Ebeling P., King J. O., Zapf P. Myopathy and malignant hyperpyrexia. Lancet. 1970 May 30;1(7657):1138–1140. doi: 10.1016/s0140-6736(70)91215-8. [DOI] [PubMed] [Google Scholar]
  16. Denborough M. A., Forster J. F., Hudson M. C., Carter N. G., Zapf P. Biochemical changes in malignant hyperpyrexia. Lancet. 1970 May 30;1(7657):1137–1138. doi: 10.1016/s0140-6736(70)91214-6. [DOI] [PubMed] [Google Scholar]
  17. ENGLHARDT-GOLKEL A., LOBEL R., SEITZ W., WOLLER I. Uber das Verhalten und die Herkunft glykolytischer Serumenzyme beim Menschen und ihre diagnostische Bedeutung. Klin Wochenschr. 1958 May 15;36(10):462–468. doi: 10.1007/BF01484638. [DOI] [PubMed] [Google Scholar]
  18. Ekbom K., Hed R., Herdenstam C. G., Nygren A. The serum creatine phosphokinase activity and the Achilles reflex in hyperthyroidism and hypothyroidism. Acta Med Scand. 1966 Apr;179(4):433–440. doi: 10.1111/j.0954-6820.1966.tb05480.x. [DOI] [PubMed] [Google Scholar]
  19. Emery A. E., Spikesman A. M. Serum creatine kinase levels. Br Med J. 1970 Jun 27;2(5712):790–790. doi: 10.1136/bmj.2.5712.790-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. GOBLE A. J., O'BRIEN E. N. Acute myocardial ischaemia: significance of plasma-transaminase activity. Lancet. 1958 Oct 25;2(7052):873–877. doi: 10.1016/s0140-6736(58)92305-5. [DOI] [PubMed] [Google Scholar]
  21. GRAIG F. A., ROSS G. Serum creatine-phosphokinase in thyroid disease. Metabolism. 1963 Jan;12:57–59. [PubMed] [Google Scholar]
  22. GRAIG F. A., SMITH J. C. SERUM CREATINE PHOSPHOKINASE ACTIVITY IN ALTERED THYROID STATES. J Clin Endocrinol Metab. 1965 Jun;25:723–731. doi: 10.1210/jcem-25-6-723. [DOI] [PubMed] [Google Scholar]
  23. Griffiths P. D. Serum levels of ATP: creatine phosphotransferase (creatine kinase). The normal range and effect of muscular activity. Clin Chim Acta. 1966 Apr;13(4):413–420. doi: 10.1016/0009-8981(66)90230-0. [DOI] [PubMed] [Google Scholar]
  24. HESS J. W., MACDONALD R. P., FREDERICK R. J., JONES R. N., NEELY J., GROSS D. SERUM CREATINE PHOSPHOKINASE (CPK) ACTIVITY IN DISORDERS OF HEART AND SKELETAL MUSCLE. Ann Intern Med. 1964 Dec;61:1015–1028. doi: 10.7326/0003-4819-61-6-1015. [DOI] [PubMed] [Google Scholar]
  25. Hedworth-Whitty R. B., Whitfield J. B., Richardson R. W. Serum gamma-glutamyl transpeptidase activity in myocardial ischaemia. Br Heart J. 1967 May;29(3):432–438. doi: 10.1136/hrt.29.3.432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Hunter P. R., Endrey-Walder P., Bauer G. E., Stephens F. O. Myocardial infarction following surgical operations. Br Med J. 1968 Dec 21;4(5633):725–728. doi: 10.1136/bmj.4.5633.725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Isaacs H., Barlow M. B. Malignant hyperpyrexia during anaesthesia: possible association with subclinical myopathy. Br Med J. 1970 Jan 31;1(5691):275–277. doi: 10.1136/bmj.1.5691.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. KING J., WAIND A. P. Lactic dehydrogenase activity in acute myocardial infarction. Br Med J. 1960 Nov 5;2(5209):1361–1363. doi: 10.1136/bmj.2.5209.1361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Kalow W., Britt B. A., Terreau M. E., Haist C. Metabolic error of muscle metabolism after recovery from malignant hyperthermia. Lancet. 1970 Oct 31;2(7679):895–898. doi: 10.1016/s0140-6736(70)92069-6. [DOI] [PubMed] [Google Scholar]
  30. Kibe O., Nilsson N. J. Observations on the diagnostic and prognostic value of some enzyme tests in myocardial infarction. Acta Med Scand. 1967 Nov;182(5):597–610. doi: 10.1111/j.0954-6820.1967.tb10886.x. [DOI] [PubMed] [Google Scholar]
  31. Killen D. A. Serum enzyme elevations. A diagnostic test for acute myocardial infarction during the early postoperative period. Arch Surg. 1968 Feb;96(2):200–210. doi: 10.1001/archsurg.1968.01330200038006. [DOI] [PubMed] [Google Scholar]
  32. LADUE J. S., WROBLEWSKI F., KARMEN A. Serum glutamic oxaloacetic transaminase activity in human acute transmural myocardial infarction. Science. 1954 Sep 24;120(3117):497–499. doi: 10.1126/science.120.3117.497. [DOI] [PubMed] [Google Scholar]
  33. LADUE J. S., WROBLEWSKI F. The significance of the serum glutamic oxalacetic transaminase activity following acute myocardial infarction. Circulation. 1955 Jun;11(6):871–877. doi: 10.1161/01.cir.11.6.871. [DOI] [PubMed] [Google Scholar]
  34. Lafair J. S., Myerson R. M. Alcoholic myopathy. With special reference to the significance of creatine phosphokinase. Arch Intern Med. 1968 Nov;122(5):417–422. doi: 10.1001/archinte.122.5.417. [DOI] [PubMed] [Google Scholar]
  35. MOLLER C. E., RAABO E. DIAGNOSTIC USE OF FRACTIONATED LACTIC DEHYDROGENASE ACTIVITY (LDH) IN MYOCARDIAL INFARCTION. Acta Med Scand. 1964 Jan;175:31–42. doi: 10.1111/j.0954-6820.1964.tb00547.x. [DOI] [PubMed] [Google Scholar]
  36. MULLAN D., DUBOWITZ V. SERUM ENZYMES IN DIAGNOSIS OF TETANUS. Lancet. 1964 Sep 5;2(7358):505–507. doi: 10.1016/s0140-6736(64)90457-x. [DOI] [PubMed] [Google Scholar]
  37. Maclean D., Griffiths P. D., Emslie-Smith D. Serum-enzymes in relation to electrocardiographic changes in accidental hypothermia. Lancet. 1968 Dec 14;2(7581):1266–1270. doi: 10.1016/s0140-6736(68)91761-3. [DOI] [PubMed] [Google Scholar]
  38. Mager M., Blatt W. F., Abelmann W. H. The use of cellulose acetate for the electrophoretic separation and quantitation of serum lactic dehydrogenase isozymes in normal and pathologic states. Clin Chim Acta. 1966 Nov;14(5):689–697. doi: 10.1016/0009-8981(66)90196-3. [DOI] [PubMed] [Google Scholar]
  39. Meltzer H. Creatine kinase and aldolase in serum: abnormality common to acute psychoses. Science. 1968 Mar 22;159(3821):1368–1370. doi: 10.1126/science.159.3821.1368. [DOI] [PubMed] [Google Scholar]
  40. Myhre E., Rasmussen K. Serum-lactic-dehydrogenase activity and intravascular haemolysis. Lancet. 1970 Feb 14;1(7642):355–355. doi: 10.1016/s0140-6736(70)90727-0. [DOI] [PubMed] [Google Scholar]
  41. NYDICK I., TANG J., STOLLERMAN G. H., WROBLEWSKI F., LADUE J. S. The influence of rheumatic fever on serum concentrations of the enzyme, glutamic oxalacetic transaminase. Circulation. 1955 Nov;12(5):795–806. doi: 10.1161/01.cir.12.5.795. [DOI] [PubMed] [Google Scholar]
  42. Nora J. J., Cooley D. A., Johnson B. L., Watson S. C., Milam J. D. Lactate dehydrogenase isozymes in human cardiac transplantation. Science. 1969 May 30;164(3883):1079–1080. doi: 10.1126/science.164.3883.1079. [DOI] [PubMed] [Google Scholar]
  43. Nutter D. O., Trujillo N. P., Evans J. M. The isoenzymes of lactic dehydrogenas. I. Myocardial infarction and coronary insufficiency. Am Heart J. 1966 Sep;72(3):315–324. doi: 10.1016/s0002-8703(66)80005-4. [DOI] [PubMed] [Google Scholar]
  44. Nygren A. Serum creatine phosphokinase activity in chronic alcoholism, in connection with acute alcohol intoxication. Acta Med Scand. 1966 May;179(5):623–630. doi: 10.1111/j.0954-6820.1966.tb07980.x. [DOI] [PubMed] [Google Scholar]
  45. OKINAKA S., KUMAGAI H., EBASHI S., SUGITA H., MOMOI H., TOYOKURA Y., FUJIE Y. Serum creatine phosphokinase. Activity in progressive muscular dystrophy and neuromuscular diseases. Arch Neurol. 1961 May;4:520–525. doi: 10.1001/archneur.1961.00450110050006. [DOI] [PubMed] [Google Scholar]
  46. OKINAKA S., SUGITA H., MOMOI H., TOYOKURA Y., WATANABE T., EBASHI F., EBASHI S. CYSTEINE-STIMULATED SERUM CREATINE KINASE IN HEALTH AND DISEASE. J Lab Clin Med. 1964 Aug;64:299–305. [PubMed] [Google Scholar]
  47. PEARSON C. M. MUSCULAR DYSTROPHY. REVIEW AND RECENT OBSERVATIONS. Am J Med. 1963 Nov;35:632–645. doi: 10.1016/0002-9343(63)90135-9. [DOI] [PubMed] [Google Scholar]
  48. RESNIK W. H. Preinfarction angina. II. An interpretation. Mod Concepts Cardiovasc Dis. 1962 Nov;31:757–761. [PubMed] [Google Scholar]
  49. RICHTERICH R., GAUTIER E., EGLI W., ZUPPINGER K., ROSSI E. [Progressive muscular dystrophy. I. The heterogenicity of serum lactic dehydrgenase]. Klin Wochenschr. 1961 Apr 1;39:346–352. doi: 10.1007/BF01492249. [DOI] [PubMed] [Google Scholar]
  50. ROSALKI S. B. SERUM ALPHA-HYDROXYBUTYRATE DEHYDROGENASE: A NEW TEST FOR MYOCARDIAL INFARCTION. Br Heart J. 1963 Nov;25:795–802. doi: 10.1136/hrt.25.6.795. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. ROSALKI S. B., WILKINSON J. H. Reduction of alpha-ketobutyrate by human serum. Nature. 1960 Dec 24;188:1110–1111. doi: 10.1038/1881110a0. [DOI] [PubMed] [Google Scholar]
  52. Ravens K. G., Gudbjarnason S., Cowan C. M., Bing R. J. Gamma-glutamyl-transpeptidase in myocardial infarction. Clinical and experimental studies. Circulation. 1969 May;39(5):693–700. doi: 10.1161/01.cir.39.5.693. [DOI] [PubMed] [Google Scholar]
  53. Richterich R., Rosin S., Aebi U., Rossi E. Progressive Muscular Dystrophy. V. The Identification of the Carrier State in the Duchenne Type by Serum Creatine Kinase Determination. Am J Hum Genet. 1963 Jun;15(2):133–154. [PMC free article] [PubMed] [Google Scholar]
  54. Runde I., Dale J. Serum enzymes in acute tachycardia. Acta Med Scand. 1966 May;179(5):535–541. doi: 10.1111/j.0954-6820.1966.tb07970.x. [DOI] [PubMed] [Google Scholar]
  55. SCHAPIRA G., DREYFUS J. C. Lacticodéhydrase plasmatique au cours des myopathies. C R Seances Soc Biol Fil. 1957;151(1):22–23. [PubMed] [Google Scholar]
  56. Smith A. F. Diagnostic value of serum-creatine-kinase in coronary-care unit. Lancet. 1967 Jul 22;2(7508):178–182. doi: 10.1016/s0140-6736(67)90005-0. [DOI] [PubMed] [Google Scholar]
  57. Thompson M. W., Murphy E. G., McAlpine P. J. An assessment of the creatine kinase test in the detection of carriers of Duchenne muscular dystrophy. J Pediatr. 1967 Jul;71(1):82–93. doi: 10.1016/s0022-3476(67)80235-x. [DOI] [PubMed] [Google Scholar]
  58. Thomson W. H. The biochemical identification of the carrier state in X-linked recessive (Duchenne) muscular dystrophy. Clin Chim Acta. 1969 Nov;26(2):207–221. doi: 10.1016/0009-8981(69)90369-6. [DOI] [PubMed] [Google Scholar]
  59. VASSELLA F., RICHTERICH R., ROSSI E. THE DIAGNOSTIC VALUE OF SERUM CREATINE KINASE IN NEUROMUSCULAR AND MUSCULAR DISEASE. Pediatrics. 1965 Feb;35:322–330. [PubMed] [Google Scholar]
  60. WIELAND T., PFLEIDERER G. Nachweis der Heterogenität von Milchsäure-dehydrogenasen verschiedenen Ursprungs durch Trägerelektrophorese. Biochem Z. 1957;329(2):112–116. [PubMed] [Google Scholar]
  61. WROBLEWSKI F., GREGORY K. F. Lactic dehydrogenase isozymes and their distribution in normal tissues and plasma and in disease states. Ann N Y Acad Sci. 1961 Nov 2;94:912–932. doi: 10.1111/j.1749-6632.1961.tb35584.x. [DOI] [PubMed] [Google Scholar]
  62. WROBLEWSKI F., LADUE J. S. Serum glutamic pyruvic transaminase in cardiac with hepatic disease. Proc Soc Exp Biol Med. 1956 Apr;91(4):569–571. doi: 10.3181/00379727-91-22330. [DOI] [PubMed] [Google Scholar]
  63. WROBLEWSKI F., ROSS C., GREGORY K. Isoenzymes and myocardial infarction. N Engl J Med. 1960 Sep 15;263:531–536. doi: 10.1056/NEJM196009152631102. [DOI] [PubMed] [Google Scholar]
  64. Wilkie J. Serum-aminopherase levels in aortic dissection. Lancet. 1969 Feb 1;1(7588):261–262. doi: 10.1016/s0140-6736(69)91276-8. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology. Supplement (Ass. Clin. Path.) are provided here courtesy of BMJ Publishing Group

RESOURCES